Announcement Concerning the Recording of Extraordinary Losses of a U.S. Subsidiary of the Company and of the Suspension of Chloroprene Rubber Production

Results Presentation of FY2024

Notice Concerning Difference Between Full-Year Consolidated Earnings Forecast and Actual Results and Voluntary Return of Part of Executive Compensation

FY2024 Summary of Consolidated Financial Statements

Announcement Concerning Sale of Non-current Assets and Recording of Extraordinary Profit

FY2024 3Q Financial Results Presentation Summary of Q&A Session

Notice Regarding Personnel Changes in Representative Directors and Executive Officers

FY2024 Third Quarter Financial Results Presentation Materials

FY2024 Third Quarter Summary of Consolidated Financial Statements